THR-687

N/A

Report date: 2024/11/20 20:00:31
NME

Base Information

Drug NameTHR-687
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin antagonists
TargetsIntegrin
Therapy Area/IndicationsDiabetic macular oedemaDiabetes MellitusDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesHungaryLithuania +[5
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGalapagos Nv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxurion NvThrombogenics
Active IndicationsN/A
Inactive IndicationsDiabetic macular oedemaDiabetes MellitusDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksN/A